New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 25, 2013
10:01 EDTVET, TIVO, NFLX, MYL, SUBCY, VIAB, TEVA, NGL, HASI, WAGE, LCI, TWX, STRZA, KYTH, SAPMY, DTV, ACT, DISCA, FOXA, DIS, DISHOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 21st Century Fox (FOXA) initiated with an Outperform at FBR Capital... Actavis (ACT) initiated with a Buy at Citigroup.... DISH (DISH) initiated with an Underperform at FBR Capital... DirecTV (DTV) initiated with a Market Perform at FBR Capital... Discovery (DISCA) initiated with an Outperform at FBR Capital... Disney (DIS) initiated with an Outperform at FBR Capital... Hannon Armstrong (HASI) initiated with a Sector Perform at RBC Capital... Kythera (KYTH) initiated with a Buy at BofA/Merrill... Mylan (MYL) initiated with a Neutral at Citigroup... NGL Energy Partners (NGL) initiated with an Outperform at Raymond James... Netflix (NFLX) initiated with a Market Perform at FBR Capital... Starz (STRZA) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with a Buy at Citigroup... TiVo (TIVO) initiated with a Market Perform at FBR Capital... Time Warner (TWX) initiated with an Outperform at FBR Capital... Vermilion Energy (VET) initiated with a Neutral at Goldman... Viacom (VIAB) initiated with an Outperform at FBR Capital... Lannett (LCI) initiated with a Buy at BofA/Merrill... Subsea 7 (SUBCY) initiated with a Buy at Canaccord... Saipem (SAPMY) initiated with a Hold at Canaccord... WageWorks (WAGE) initiated with a Buy at SunTrust.
News For FOXA;ACT;DISH;DISCA;DTV;DIS;HASI;MYL;KYTH;NGL;NFLX;STRZA;TEVA;TIVO;TWX;VIAB;VET;LCI;SUBCY;SAPMY;WAGE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
April 7, 2015
15:24 EDTTEVATeva price target raised to $75 from $64 at BMO Capital
BMO Capital raised its EPS estimates for Teva (TEVA) and increased its price target on the stock to $75 from $64 on account of the expected launch of a treatment for chorea associated with Huntington’s disease in 3Q16 and a launch of a tardive dyskinesia drug in 3Q17 following the company's deal to buy Auspex (ASPX). The firm maintains its Outperform rating on Teva shares.
15:08 EDTNFLXArrested Development producer says 17 new episodes to be produced
Subscribe for More Information
12:50 EDTTWXHBO NOW available to Apple and Optimum Online customers
Subscribe for More Information
10:19 EDTMYLHigh option volume stocks
Subscribe for More Information
09:35 EDTNFLXActive equity options trading on open
Subscribe for More Information
08:31 EDTWAGEConcerns over court ruling impact on WageWorks overblown, says SunTrust
Subscribe for More Information
08:15 EDTDISCADiscovery said to bid for stake in Korean cable TV operator, Bloomberg reports
Discovery Communications was among those submitting bids for a stake in South Korean cable TV operator C&M, reported Korea Economic Daily, according to Bloomberg.
07:32 EDTMYLMylan launches Norethindrone and Ethinyl Estradiol Tablets in U.S.
Subscribe for More Information
05:10 EDTFOXA, DISDisney, Lucasfilm, 20th Century Fox announce Star Wars digital movie collection
As anticipation builds for the December release of Star Wars: The Force Awakens, Walt Disney Studios (DIS), Lucasfilm Ltd., and 20th Century Fox (FOX, FOXA) announced the upcoming release of The Star Wars Digital Movie Collection. For the first time ever, all six epic films in the Saga, from The Phantom Menace to Return of the Jedi, will be available on Digital HD globally beginning Friday, April 10.
April 6, 2015
16:12 EDTVIABViacom to temporarily pause share repurchases
Subscribe for More Information
16:10 EDTVIABViacom sees $350M annual cost savings from strategic realignment
Subscribe for More Information
16:08 EDTVIABViacom to recognize $785M pre-tax charge as part of strategic realignment
Subscribe for More Information
16:00 EDTNFLXOptions Update; April 6, 2015
iPath S&P 500 VIX Short-Term Futures down 51c to 24.53. Option volume leaders: AAPL TSLA VZ TWTR BIDU RIG NFLX AMZN KO PBR according to Track Data.
10:01 EDTDISHWeather Channel's core buiness facing 'major' threat, WSJ reports
The Weather Channel, which is owned by a consortium made up of NBCUniversal (CMCSA) and private equity firms Bain Capital and The Blackstone Group (BX), was dropped last month from Verizon's (VZ) FiOS TV service, and now the channel's backers are preparing for the possibility of being dropped by Dish Network (DISH), sources tell The Wall Street Journal. Though The Weather Channel is facing a "major" threat to its core business, the fees it collects from the pay-TV providers, the sources say that no formal sale by the company's owners is under way. Reference Link
05:56 EDTTEVATeva battles possible generic Copaxone competitors, Globes reports
A citizen's petition has been filed by Teva with the FDA against possible generic competition to its MS treatment Copaxone beginning in September, Globes reports. The FDA has previously ruled that it was "too early" to discuss the matter. Reference Link
April 5, 2015
18:34 EDTTWX, FOXA, DISComcast's 'Furious 7' leads at weekend box office with $143.6M
Subscribe for More Information
17:06 EDTDISHSling TV introduces Sling International
Sling TV announced that DishWorld, the live streaming multi-language television service, is now “Sling International.” The move officially marries the largest provider of streamed international channels in the U.S. with Sling TV, the recently-launched provider of live, over-the-top, OTT, domestic TV service. Sling International provides global programming from nearly 200 channels in 18 languages to U.S. households, starting at $15 per month. “Sling TV grew from the foundation established by DishWorld, enabling us to test, grow and improve our OTT capabilities through a service that streams tens of millions of hours of content every month,” said Roger Lynch, CEO of Sling TV. “Incorporating DishWorld into the Sling TV portfolio makes it even easier for viewers to get the best of both domestic programming and the shows and sports they love from overseas.” Sling TV is a subsidiary of DISH Network (DISH).
16:37 EDTDISDisney to invest $250M in fantasy site DraftKings, WSJ says
Subscribe for More Information
16:29 EDTNFLXNetflix's 'House of Cards' to return for fourth season
Netflix's official twitter account for "House of Cards" tweeted on Thursday the following: "I will leave a legacy." Along with the tweet was a picture with an upside down American flag that said, "Season 4 coming in 2016." Reference Link
14:43 EDTACTActavis seeks FDA approval to market generic version of Gilead's Letairis
Actavis (ACT) on Friday, confirmed that it has filed an Abbreviated New Drug Application with the FDA seeking approval to market Ambrisentan Tablets, 5 mg and 10 mg. Actavis' ANDA product is a generic version of Gilead Science's (GILD) Letairis, which is a treatment for pulmonary arterial hypertension. Gilead Sciences and Royalty Pharma Collection Trust filed suit against Actavis on April 1, in the U.S. District Court for the District of Delaware seeking to prevent Actavis from commercializing its ANDA product prior to the expiration of U.S. Patent number RE42,462. The lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Actavis' ANDA for up to 30 months from the date the plaintiffs received notice of Actavis' ANDA filing or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities. Based on available information, Actavis believes it may be a "first applicant" to file an ANDA for the generic version of Letairis and, should its ANDA be approved, may be entitled to 180 days of generic market exclusivity. For the 12 months ending December 31, Letairis had global sales of approximately $595M, according to Gilead.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use